Get started
Ajanta Pharma LimitedAjanta Pharma LimitedAjanta Pharma Limited

Ajanta Pharma Limited

No trades
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsETFs

Trade ideas

EMA 20 Strategy Unveiled with AJANTPHARM AJANTPHARM, a leading pharmaceutical company, has recently seen its stocks take a dip, positioning perfectly into the EMA 20 strategy that I'm about to unveil. Before we dive into our analysis, let's ensure we understand the strategy. 📚 The EMA 20 Strategy Explained Identify an Uptrend: Look for a Higher High-Higher Low structure. Ensure the EMA 8 lies above the EMA 20. Watch for a candle that touches the EMA 20. Wait for the next candle to close higher than the previous one's close (should be above ema 20). Confirm the Higher High-Higher Low structure remains intact. Analyse Weekly & Monthly Zones: Reject trades in the Supply Zone (SZ) but consider ones in the Demand Zone (DZ). 📈 AJANTPHARM's EMA 20 Story Given AJANTPHARM's recent trading at an all-time high with no higher timeframe supply zone, it's positioned favourably. Recently, the price closed below the EMA 20, only to rebound and close higher the next day. With the 8 EMA positioned above the 20 EMA, this stock is an ideal candidate for the EMA 20 strategy. This strategy can be deployed for stocks at an all-time high or those on a healthy uptrend. ✨ Why EMA 20? Algo traders have let slip that many among them use the daily EMA 20 for stock entry decisions. This insight has rendered the EMA 20 a potent magnet for trending stocks. However, before deploying this strategy, ensure that the stock price respects the EMA 20. 💰 Strategy in Action Place your stop loss (SL) below the pullback candle's low. Plan your buy entry above today's high, targeting a risk-to-reward ratio of at least 1:2. If you've found this analysis helpful, please hit the 🚀 icon, leave a comment, and follow my profile for more insights! Thank you for your continued support and feedback. Always strive to improve and keep learning. Dive deeper into my analyses and strategies at in.tradingview.com 💡 Tip : This strategy shines with stocks at all-time highs or those experiencing a solid uptrend. “Trade with passion, not with emotion.” 💡 Please note, this analysis is for educational purposes only. I am not a SEBI registered analyst.
NSE:AJANTPHARMLong
by AfnanTAjuddin
7
Go Long with Ajanta Pharma for swing trade Aggressive Traders can go long with Ajanta Pharma at CMP around 1300 with SL around 1250-1260 and target 1330, 1400 and final target around 1440-1460. It may consolidate near 1460 for few days before next move. Conservative traders should enter near 1190, if get chance, with SL around 1140. Target depends on next price action. Same targets can be considered if major selling pressure is not seen before reaching to entry point (1190). DISCLAIMER:- I'm not SEBI Registered. Ideas shared here are my personal view and not to take trades, these are for educational purpose only. Please consult your investment/trading advisor before taking any position.
NSE:AJANTPHARMLong
by anilpatidar
Ajanta Pharma building long positionTranche 1 - 30 shares at 1765 on 5 April 2022 1. Market is in what stage - Identified by what kind of highs and lows that are being formed + movement of price w.r.t 21, 50 and 200 EMA Price topped out July, then in range till Jan 2022 (2340 to 2000) broke down and bounced at 1700, came back to 1768 2. Is there any trend reversal in play? 1. Multiple divergence confirmations on MACD , RSI and MFI - Possibility on daily 2. At important support or resistance - horizontal - Yes - Yes long term resistance truned solid support at 1700 3. At important confluence of EMAs + price + support - Yes - around Weekly 200 3. How are the candlesticks behaving and what is the volume doing Good buying when it had previously come at this level so expecting consolidation and bounce from here... plan to add more 4. Is there any trend continuation in play? Looks like a bounce from a major support 5. Is there any pullback or breakout in play with volume confirmation from a strong horizontal level (support or resistance) No pullbacks or breakouts as of now 6. Fundamental factors in play 1. Revenue growth - EPS vs PE ratio - last 5 years comparison - EPS rising Quarterly and Yearly... because of better sales... OPMs is consistent... also PE ratio to EPS is very very attractive since 2019 2. Are institutional investors/promotors increasing their stake - Stake consistent mostly slight increase in DII and slight decrease in retail
NSE:AJANTPHARMLong
by Golden_Ratio_Capital